First Command Advisory Services’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
RCM
PBA
First Command Advisory Services's PCVX Position: Q2 2025 in Review
First Command Advisory Services sold out of Vaxcyte (PCVX) in Q2 2025, closing a stake of 17 shares — an estimated $642 sold.
First Command Advisory Services first reported a position in PCVX in Q1 2025 and held it in 1 quarter. The position peaked at $642 in Q1 2025. 294 funds tracked by Wall St. Rank hold PCVX as of Q2 2025.
- First Command Advisory Services reported no remaining Vaxcyte position as of Q2 2025 after selling out during the quarter.
- First Command Advisory Services sold 17 Vaxcyte shares in Q2 2025, an estimated $642.
- First Command Advisory Services first reported a position in Vaxcyte in Q1 2025 and held it in 1 quarter.
- First Command Advisory Services's Vaxcyte position peaked at $642 in Q1 2025.
- 294 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2025.
Based on First Command Advisory Services's 13F filing for Q2 2025, filed 1 Aug 2025.